[{"address1": "2450 Holcombe Blvd.", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "(713) 913-5608", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Arthur M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 726185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5993, "open": 0.6683, "dayLow": 0.5891, "dayHigh": 0.7, "regularMarketPreviousClose": 0.5993, "regularMarketOpen": 0.6683, "regularMarketDayLow": 0.5891, "regularMarketDayHigh": 0.7, "payoutRatio": 0.0, "beta": 0.443, "forwardPE": -0.06870229, "volume": 4036398, "regularMarketVolume": 4036398, "averageVolume": 3114095, "averageVolume10days": 11854770, "averageDailyVolume10Day": 11854770, "bid": 0.4805, "ask": 0.767, "bidSize": 2, "askSize": 2, "marketCap": 1340192, "fiftyTwoWeekLow": 0.452, "fiftyTwoWeekHigh": 7.2, "fiftyDayAverage": 0.80362, "twoHundredDayAverage": 1.23582, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -345959, "profitMargins": 0.0, "floatShares": 2116543, "sharesOutstanding": 2127290, "sharesShort": 678491, "sharesShortPriorMonth": 31420, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.3189, "heldPercentInsiders": 0.01705, "heldPercentInstitutions": 0.065749995, "shortRatio": 0.19, "shortPercentOfFloat": 0.3206, "impliedSharesOutstanding": 2127290, "bookValue": 0.03, "priceToBook": 21.0, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -5570020, "trailingEps": -3.55, "forwardEps": -9.17, "lastSplitFactor": "1:8", "lastSplitDate": 1718582400, "enterpriseToEbitda": 0.061, "52WeekChange": -0.64, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 0.63, "recommendationKey": "none", "totalCash": 1798380, "totalCashPerShare": 0.845, "ebitda": -5676973, "totalDebt": 112230, "quickRatio": 0.79, "currentRatio": 1.012, "debtToEquity": 181.408, "returnOnAssets": -0.98320997, "returnOnEquity": -3.0015702, "freeCashflow": -2318306, "operatingCashflow": -4353096, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "postMarketChangePercent": 2.12699, "postMarketPrice": 0.6434, "postMarketChange": 0.0134, "regularMarketChange": 0.0307, "regularMarketDayRange": "0.5891 - 0.7", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3114095, "fiftyTwoWeekLowChange": 0.178, "fiftyTwoWeekLowChangePercent": 0.39380533, "fiftyTwoWeekRange": "0.452 - 7.2", "fiftyTwoWeekHighChange": -6.5699997, "fiftyTwoWeekHighChangePercent": -0.91249996, "fiftyTwoWeekChangePercent": -64.0, "dividendDate": 1563753600, "earningsTimestamp": 1747252800, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.55, "epsForward": -9.17, "fiftyDayAverageChange": -0.17361999, "fiftyDayAverageChangePercent": -0.21604738, "twoHundredDayAverageChange": -0.60582006, "twoHundredDayAverageChangePercent": -0.49021706, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1754092685, "regularMarketTime": 1754078400, "marketState": "CLOSED", "regularMarketChangePercent": 5.12264, "regularMarketPrice": 0.63, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]